Rhinovirus prevalence as indicator for efficacy of measures against SARS-CoV-2
Rhinovirus prevalence as indicator for efficacy of measures against SARS-CoV-2
About this item
Full title
Author / Creator
Publisher
England: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
Non-pharmaceutical measures to control the spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) should be carefully tuned as they can impose a heavy social and economic burden. To quantify and possibly tune the efficacy of these anti-SARS-CoV-2 measures, we have devised indicators based on the abundant historic and current prevale...
Alternative Titles
Full title
Rhinovirus prevalence as indicator for efficacy of measures against SARS-CoV-2
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_e84e2a6beee44ef3b4530811009aedcd
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_e84e2a6beee44ef3b4530811009aedcd
Other Identifiers
ISSN
1471-2458
E-ISSN
1471-2458
DOI
10.1186/s12889-021-11178-w
